It is, therefore, possible that PI3K/AKT signaling downstream of BAFF-R is disease-specific, cell-type specific, or even depends on the maturation stage of the B cells, considering that HCL is a mature B-cell neoplasm [9]. The gene discussed is TNFRSF13C; the disease is B-cell neoplasm.